Home > Press > News > 2016

Apolipoproteins - new perspectives for lipid profilling, but other challenges remain

Read the article
Pan Global - www.cli-online.com - Dec-Jan 2016

Atherosclerotic cardiovascular diseases (CVD) are the leading cause of death in the West, and dyslipidemia is considered to be one of their key risk factors. The majority of CVD cases could be prevented by effective management of dyslipidemia. The use of new biomarkers like apolipoproteins as part of extended lipid profiles may be among the most significant new tools for such a task.